Key facts
- This page summarizes Hubert C. Chen's Form 4 filing for Metacrine, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 May 2021, 18:54.
Hubert C. Chen - 20 May 2021 Form 4 Insider Report for Metacrine, Inc.
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- N/A
- Reported as of
- 20 May 2021
- Net transaction value
- +$11,840
- SEC form
- 4
- Accepted by SEC
- 20 May 2021, 18:54:06 UTC
- Next SEC filing
- 08 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Catherine C. Lee, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Hubert C. Chen filed Form 4 for Metacrine, Inc. on 20 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$11,840.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MTCR
transaction
Common Stock
Purchase
- Transaction value
- $11,840
- Shares
- +3,289
- Change %
- Price
- $3.60*
- Shares after
- 3,289
- Date
- 20 May 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.